Log in to save to my catalogue

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a sy...

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a sy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2310295686

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials

About this item

Full title

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal of neurology, neurosurgery and psychiatry, 2020-01, Vol.91 (1), p.21-32

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

ObjectivesTo systematically review the efficacy and safety of anti-inflammatory agents for patients with major depressive disorders.MethodsWe searched the literature to identify potentially relevant randomised controlled trials (RCTs) up to 1 January 2019. The primary outcome was efficacy, measured by mean changes in depression score from baseline...

Alternative Titles

Full title

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2310295686

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2310295686

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp-2019-320912

How to access this item